Skip to content

Industrial Pharmacist

  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy
  • ANDA
  • ADL
  • FRD
  • QbD
  • QA
  • QC
  • RA
  • FDA
  • VS
  • SCM
  • Q&A
  • Dissolution
  • Data Integrity
  • Validation
  • Manufacturing
  • Packaging
  • Microbiology
Industrial Pharmacist
  • The Role and Duties of the EU Qualified Person (QP) | Part I
    QP

    The Role and Duties of the EU Qualified Person (QP) | Part I

    Byipharmacist August 19, 2023September 10, 2024

      The concept of the Qualified Person (QP), first established in 1975, is a unique regulatory requirement which applies within the European Union (EU).   The only comparable situation exists within Member States of the European Economic Area (EEA) with whom the EU has reciprocal agreements.   Each holder of an Authorisation to Manufacture products…

    Read More The Role and Duties of the EU Qualified Person (QP) | Part IContinue

  • Validation of Compendial Methods
    Analytical Development

    Validation of Compendial Methods

    Byipharmacist August 18, 2023September 10, 2024

      Test procedures for assessment of the quality levels of pharmaceutical products are subject to various requirements.   According to Section 501 of the Federal Food, Drug, and Cosmetic Act, assays and specifications in monographs of the USP Pharmacopeia and the National Formulary constitute legal standards.   The cGMP regulations [21 CFR 211.194(a)] require that…

    Read More Validation of Compendial MethodsContinue

  • How do you Study the Effect of Filtration on Sample during Analytical Method Validation?
    Analytical Development

    How do you Study the Effect of Filtration on Sample during Analytical Method Validation?

    Byipharmacist August 18, 2023September 10, 2024

    Filtration can have significant effects on the results of analytical method validation, particularly in sample preparation and analysis processes.   Filtration plays a role in method validation in several ways:   Filtration study, the sample should be filtered through the proposed filter and the results should be compared with the unfiltered (centrifuged) sample.   Acceptance…

    Read More How do you Study the Effect of Filtration on Sample during Analytical Method Validation?Continue

  • Regulatory Affairs Interview Questions
    ANDA | eCTD | Interview Questions | NDA | Q&A | Regulatory Affairs

    Regulatory Affairs Interview Questions

    Byipharmacist August 17, 2023September 10, 2024

    Most relevant interview questions for freshers and experienced candidate applying for Regulatory Affairs positions in the US market, specifically in the context of generic submission (ANDAs):   For Freshers 1. Can you explain what an ANDA is and its significance in the generic drug approval process?   2. How do you envision your role as…

    Read More Regulatory Affairs Interview QuestionsContinue

  • Mandatory Activities for GMP Authorization of a New Pharmaceutical Facility
    GMP

    Mandatory Activities for GMP Authorization of a New Pharmaceutical Facility

    Byipharmacist August 16, 2023September 10, 2024

    Obtaining GMP authorization for a new pharmaceutical facility entails a detailed process to ensure regulatory compliance and safe product production. Here’s a comprehensive overview of necessary activities:   1. Facility Design and Construction: – Develop layout adhering to GMP, zoning different areas. – Construct with materials preventing contamination.   2. Cleanroom Design and Qualification: –…

    Read More Mandatory Activities for GMP Authorization of a New Pharmaceutical FacilityContinue

  • Tips for Optimizing HPLC Method in Pharmaceutical Analysis
    Analytical Development | HPLC

    Tips for Optimizing HPLC Method in Pharmaceutical Analysis

    Byipharmacist August 16, 2023September 10, 2024

    Discovering straightforward tips for success in optimizing HPLC methods: 1. Use the appropriate column for your analytes and separation goals. 2. Optimize the mobile phase composition, including solvent type and concentration. 3. Adjust the pH of the mobile phase if necessary. 4. Optimize the flow rate to achieve optimal separation and resolution. 5. Use the…

    Read More Tips for Optimizing HPLC Method in Pharmaceutical AnalysisContinue

  • Difference Between (NDA) 505(b)(1) and  (NDA) 505(b)(2)
    Regulatory Affairs | VS

    Difference Between (NDA) 505(b)(1) and (NDA) 505(b)(2)

    Byipharmacist August 12, 2023September 10, 2024

    Ever wondered about the difference between a completely new drug (NDA) 505(b)(1)and a hybrid drug (NDA)505(b)(2)? Let’s explore the contrast between these two pathways!   A 505(b)(2) New Drug Application (NDA) is a regulatory pathway in the United States that allows for the submission and approval of certain new drug products. The name “505(b)(2)” comes…

    Read More Difference Between (NDA) 505(b)(1) and (NDA) 505(b)(2)Continue

  • Deviations Management: From Root Cause to Resolution
    Deviation | QRM

    Deviations Management: From Root Cause to Resolution

    Byipharmacist August 12, 2023October 25, 2024

    Managing deviations and investigations efficiently is critical to ensuring product quality, compliance with regulations, and continuous improvement.    An effective quality management system (QMS) must include procedures to identify, document, segregate, evaluate, and disposition production and post-production issues.    You need to report and document the deviation as soon as it is identified. This includes…

    Read More Deviations Management: From Root Cause to ResolutionContinue

Page navigation

Previous PagePrevious 1 … 36 37 38 39 40 … 43 Next PageNext

Popular Articles

  • Calculation of Peak Purity in HPLC

    Calculation of Peak Purity in HPLC

  • Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

    Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

  • Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

    Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

  • Audits in the Pharmaceutical Industry | Internal vs External

    Audits in the Pharmaceutical Industry | Internal vs External

  • USFDA Complaint Laboratory KPIs Measurements

    USFDA Complaint Laboratory KPIs Measurements

  • Difference Between Generic ANDA and 505(b)(2) Submissions

    Difference Between Generic ANDA and 505(b)(2) Submissions

  • Difference Between Disinfection and Sterilization

    Difference Between Disinfection and Sterilization

  • Key Elements of an Analytical Worksheet

    Key Elements of an Analytical Worksheet

  • Interview Questions and Answers on GMP

    Interview Questions and Answers on GMP

  • Quality by Design (QbD) and Design Space in Pharmaceutical Development

    Quality by Design (QbD) and Design Space in Pharmaceutical Development

  • CPP and CQA in Different Stages of Drug Product Manufacturing

    CPP and CQA in Different Stages of Drug Product Manufacturing

  • FDA Recall Classification System

    FDA Recall Classification System

  • Analytical Test Method Validation and Verification

    Analytical Test Method Validation and Verification

  • GLP vs GMP vs GCP | Similarities and Differences

    GLP vs GMP vs GCP | Similarities and Differences

  • Pharmaceutical Validation Interview Questions and Answers

    Pharmaceutical Validation Interview Questions and Answers

  • Difference Between Purity and Potency

    Difference Between Purity and Potency

  • Difference Between RLD and RS

    Difference Between RLD and RS

  • USFDA Databases

    USFDA Databases

  • Regulatory Requirements for Reprocess and Re-work

    Regulatory Requirements for Reprocess and Re-work

  • What Does FDA Regulate?

    What Does FDA Regulate?

© 2025 Industrial Pharmacist

  • Privacy Policy
  • DMCA
  • Contact Us
Industrial Pharmacist
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy